Search results for: 'research preview docunited states infectious disease (point care) testing poct market'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...

16 Feb 2021  |  North America  |  Market Research

Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market

Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care

Infographics

×

Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...

Before the introduction of Internet of Things (IoT) technologies in healthcare, patients’ interactions with doctors were often limited to clinic visits, text or tele communications. Due to this doctors were not able to monitor patients’ health continuously and this was affecting the overall treatment outcome. To address this clinical concern, resea...

The objective of this study is to identify the key trends prevailing in the global modular test equipment market and examine the factors that boost and restrain the growth of the market. The study also discusses the product areas that bolster growth for the forecast period (2021 to 2027). The research provides estimates of the market size and futur...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

COVID-19 brought about major changes for companies and industries globally, followed by a recovery of operations in 2021. 2022 began with the war between Russia and Ukraine, which created fears of a global recession and inflation, resulting in uncertainties among manufacturers to plan future investments. While Europe is likely to be affected more, ...

18 Nov 2021  |  Global  |  Market Research

Global Terabit Ethernet Testing Solutions Growth Opportunities

Future Growth Potential Encouraged by 5G Deployments, Rapid Developments in Next Generation 800GbE and 1.6TbE, and Hyperscale Clou

Infographics

×

The global terabit ethernet (TbE) testing solutions market was worth $62.3 million in 2020 and will reach $203.6 million by 2025, corresponding to incremental growth of $141.3 million and a compound annual growth rate (CAGR) of 26.7% between 2020 and 2025. The market had exorbitant growth rates in 2019 and 2020; however, as the technology matures, ...

This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects: Technology roadmap, market trends, capabilities, and targeted application Stakeholder activities, influence, industry initiatives Investment environment and funding support Industry evolution and ...